Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2009 (2009), Article ID 934579, 7 pages
Research Article

Serodeconversion of HIV Antibody-Positive AIDS Patients Following Treatment with V-1 Immunitor

1Occupational and Environmental Medicine Association of Thailand, Rajavithi General Hospital, Ministry of Public Health, Rajavithi Road, Bangkok 10400, Thailand
2Immunitor USA Inc., 9308 48th Avenue, College Park, MD 20740, USA

Received 30 May 2008; Revised 7 August 2008; Accepted 7 September 2008

Academic Editor: Ali Ouaissi

Copyright © 2009 Orapun Metadilogkul et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


It is extremely rare when HIV seropositive adult patients experience spontaneous loss of antibodies, that is, seroreversion. The disappearance of HIV antibodies was occasionally attributed to iatrogenic intervention—serodeconversion. Such interventions include: HAART; oral interferon; Chinese herbal remedies; and therapeutic AIDS vaccines derived from pooled blood. Oral therapeutic, alloimmune AIDS vaccine, V-1 Immunitor (V1), was administered to 60000 HIV-positive Thai patients. The administration of V1 resulted in serodeconversion among 23 individuals. The patient group consisted of 9 females (39%) and 14 males (61%) including two 2-year-old boys. The age range was 2–58 years with mean/median 29/29.3 years. Patients were tested seropositive for HIV at least once before being enrolled on V1. The duration of treatment until discovery of seronegative status ranged between 2 weeks and 15 months with average/median 7.2/8 months. Time to seronegativity was correlated with baseline disease stage ( 𝑅 = 0 . 6 2 ; 𝑃 = . 0 0 2 ). The seronegative status was positively associated with V1-induced undetectable or low viral load ( 𝑅 = 0 . 6 5 ; 𝑃 = . 0 0 0 8 ). The odds ratio analysis comparing the outcome of our study with published surveys of diagnostic accuracy of laboratory tests suggested that the probability of HIV antibody testing error was remote ( 𝑃 < . 0 0 0 0 0 1 ). The possible causes responsible for this unusual phenomenon are discussed.